1. jesacoyote77
2. supper3638
3. tv52898
4. dmchof94
1.jesacoyote77 04/17/2018
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
2.tv52898 02/22/2018
seems accurate
3.dmchof94 02/22/2018
{Image}
4.dmchof94 04/17/2018
Looking to add some
5.supper3638 04/17/2018
Enters into license agreement with Basilea Pharmaceutica; Basilea will make an upfront payment to ArQule of …
6.supper3638 02/07/2018
ArQule and Roivant Sciences initiate a collaboration to pursue the development of derazantinib in Greater Ch…
7.jesacoyote77 02/04/2018
B. Riley FBR, Inc. raises to buy
8.jesacoyote77 02/22/2018
Wow, this is a double
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW